KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Other Non-Current Assets (2016 - 2025)

Teladoc Health's Other Non-Current Assets history spans 12 years, with the latest figure at $105.8 million for Q4 2025.

  • For Q4 2025, Other Non-Current Assets rose 29.84% year-over-year to $105.8 million; the TTM value through Dec 2025 reached $105.8 million, up 29.84%, while the annual FY2025 figure was $105.8 million, 29.84% up from the prior year.
  • Other Non-Current Assets for Q4 2025 was $105.8 million at Teladoc Health, down from $106.7 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $108.8 million in Q1 2025 and bottomed at $17.9 million in Q3 2021.
  • The 5-year median for Other Non-Current Assets is $73.7 million (2023), against an average of $63.8 million.
  • The largest annual shift saw Other Non-Current Assets soared 151.37% in 2021 before it dropped 4.9% in 2022.
  • A 5-year view of Other Non-Current Assets shows it stood at $20.7 million in 2021, then surged by 134.46% to $48.5 million in 2022, then soared by 65.34% to $80.3 million in 2023, then rose by 1.53% to $81.5 million in 2024, then grew by 29.84% to $105.8 million in 2025.
  • Per Business Quant, the three most recent readings for TDOC's Other Non-Current Assets are $105.8 million (Q4 2025), $106.7 million (Q3 2025), and $101.1 million (Q2 2025).